Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort

OBJECTIVES: Developing disease modifying therapies for Parkinson’s disease (PD) calls for outcome measurement strategies focused on characterizing early stage disease progression. We explored the psychometric evidence for using the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (...

Descripción completa

Detalles Bibliográficos
Autores principales: Regnault, Antoine, Boroojerdi, Babak, Meunier, Juliette, Bani, Massimo, Morel, Thomas, Cano, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647182/
https://www.ncbi.nlm.nih.gov/pubmed/31073716
http://dx.doi.org/10.1007/s00415-019-09348-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647182/
https://www.ncbi.nlm.nih.gov/pubmed/31073716
http://dx.doi.org/10.1007/s00415-019-09348-3

Ejemplares similares